No abstract

Performance of broiler chicks fed low protein diets supplemented with several essential amino acids (EAA) is generally inferior to that of birds fed a higher protein diet composed primarily of intact protein. Two experiments were conducted to determine whether lowering the minimum requirements of the EAA in proportion to the lowered protein concentration or equalizing the dietary amino nitrogen content by use of glutamic acid would prevent the reduction in performance. Chicks were fed the experimental diets from 7 to 21 days of age, and body weight gain, feed consumption, and feed efficiency were determined. In the first experiment, the chicks were fed diets with 23, 20, or 17% CP with minimum EAA set at 100% of the 1984 National Research Council (NRC) suggested requirements. Other groups were fed the 20% CP diet with EAA set at 93.5% or the 17% CP diet set at either 93.5 or 87.5% of the NRC requirements. In the second experiment, the 23% and 17% CP diets were fed, and glutamic acid was added at 3, 6, or 9% to provide the amino nitrogen equivalent of 23% protein with the minimum EAA set at 100% of 1984 NRC requirements. In the first experiment, body weight gain and feed efficiency, but not feed intake, were depressed by lowering CP content. Reducing the minimum EAA requirements in proportion to the reduction in CP failed to correct the difference in performance between the high and low CP diets. In Experiment 2, body weight gain and feed intake were reduced as intact CP decreased and glutamic acid increased, but feed efficiency was unaffected.(ABSTRACT TRUNCATED AT 250 WORDS)

One thousand male Hubbard chicks were used in a 21-d study (10 birds per battery cage) to determine relative biological availability of phosphorus in seven samples of commercial dicalcium phosphate, expected to contain variable amounts of monocalcium phosphate. Five samples were from established producers in Brazil and two from the U.S. Pure calcium phosphate dibasic dihydrate was used as the reference standard. Phosphates were added to the corn-soybean basal diet (22.5% CP; 0.4% total phosphorus) to provide 0.1, 0.2, and 0.3% supplemental phosphorus. The calcium level was 1.0% for all diets. Left tibias were removed for bone ash (BA) and bone strength (BS) determination. Body weight, feed intake (FI), BA, BS, and plasma phosphorus increased (P < 0.01) and plasma calcium and alkaline phosphatase decreased (P < 0.01) with increasing dietary phosphorus regardless of source. The availability of phosphorus for each test phosphate was determined by slope ratio, with BW, BA, and BS regressed on phosphorus added within each phosphorus source. A relative biological value (RBV) was calculated based on BW, BA, and gain:feed ratio. Availability based on BW ranged from 97.07 to 110.41%. When BA was the criterion, values were 80.32 to 107.84% and for BS were 79.34 to 110.52%. The RBV ranged from 97.55 to 100.60%. Phosphate sources did not vary greatly in phosphorus availability. Overall phosphorus availability averages were higher for BW (103%) and RBV (99%) and lowest for BA (96%) and BS (94%).

To evaluate the effect of lipid-lowering agents upon egg quality, reproductive performance, plasma lipids, and egg yolk cholesterol levels, 30-week-old Shaver laying hens were fed a basal diet (commercial ration) supplemented with 0.1% probucol (PROB), 0.025% gemfibrozil (GEMF), or lovastatin at 0.0005% (LOV1), 0.001% (LOV2), or 0.0015% (LOV3) for a 12-week experimental period. It was observed that the supplementation of the drugs did not impair albumen and shell quality. Hen performance was not adversely affected. The depression in triglyceride concentrations approached statistical significance only in LOV2 (38.5%), and total cholesterol was significantly depressed in LOV2 (36.0%), LOV3 (36.8%), PROB (29.6%), and GEMF (30.4%) treatments. Egg cholesterol content, expressed per gram of yolk, was significant lowered in LOV1 (7.5%) and LOV3 (12. 7%).

No abstract